Probi secures strategic US order
Probi has secured a major order valued at MSEK 3.6 from the US self-care product company Pharmavite. The order pertains to the dietary supplement Probi Digestis®, which promotes gastrointestinal health. The order is based on strong demand for Probi’s digestive health capsules in US pharmacies and retail stores. The order consisting of a number of part shipments will be delivered during the second and third quarter of 2014. This is one of the largest orders ever received by Probi in the Consumer Healthcare business area. “Our partnership with Pharmavite has been expanded over the past